These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17372135)

  • 1. Hepatitis B reactivation during glioblastoma treatment with temozolomide: a cautionary note.
    Chheda MG; Drappatz J; Greenberger NJ; Kesari S; Weiss SE; Gigas DC; Doherty LM; Wen PY
    Neurology; 2007 Mar; 68(12):955-6. PubMed ID: 17372135
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatal reactivation of hepatitis B with temozolomide.
    Grewal J; Dellinger CA; Yung WK
    N Engl J Med; 2007 Apr; 356(15):1591-2. PubMed ID: 17429098
    [No Abstract]   [Full Text] [Related]  

  • 3. Glioblastoma multiforme and hepatitis B: do the right thing(s).
    Purchiaroni F; Begini P; Minniti G; Gallina S; Delle Fave G; Marignani M
    Eur Rev Med Pharmacol Sci; 2014; 18(23):3629-31. PubMed ID: 25535132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivation of hepatitis B virus after glioblastoma treatment with temozolomide--case report.
    Ohno M; Narita Y; Miyakita Y; Ueno H; Kayama T; Shibui S
    Neurol Med Chir (Tokyo); 2011; 51(10):728-31. PubMed ID: 22027252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid related idiosyncratic drug induced hepatotoxicity in a glioblastoma patient treated with temozolomide.
    Neyns B; Hoorens A; Stupp R
    Acta Neurol Belg; 2008 Dec; 108(4):131-4. PubMed ID: 19239041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant viral and bacterial encephalitis after temozolomide for glioblastoma.
    Tsai JP; Petrescu N; Mason WP; Casaubon LK
    Can J Neurol Sci; 2014 Jan; 41(1):84-5. PubMed ID: 24384343
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis B virus reactivation associated with temozolomide for malignant glioma: a case report and recommendation for prophylaxis.
    Fujimoto Y; Hashimoto N; Kinoshita M; Miyazaki Y; Tanaka S; Yakushijin T; Takehara T; Kagawa N; Yoshimine T
    Int J Clin Oncol; 2012 Jun; 17(3):290-3. PubMed ID: 21809177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment-related Acute Myeloid Leukaemia After Temozolomide for Glioblastoma Multiforme.
    Tan CW; See SJ; Tham CK; Ang AL
    Ann Acad Med Singap; 2014 Jun; 43(6):334-7. PubMed ID: 25028145
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis B reactivation prophylaxis in immune-suppressed patients.
    Torresin A; Feasi M; Cassola G
    Haematologica; 2008 Nov; 93(11):e65. PubMed ID: 18978291
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term outcome after prophylactic lamivudine treatment on hepatitis B virus reactivation in non-Hodgkin's lymphoma.
    Kim JS; Hahn JS; Park SY; Kim Y; Park IH; Lee CK; Cheong JW; Lee ST; Min YH
    Yonsei Med J; 2007 Feb; 48(1):78-89. PubMed ID: 17326249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitus B virus reactivation in HBV-DNA negative and positive patients with hematological malignancies.
    Yağci M; Ozkurt ZN; Yeğin ZA; Aki Z; Sucak GT; Haznedar R
    Hematology; 2010 Aug; 15(4):240-4. PubMed ID: 20670484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus reactivation and alemtuzumab therapy.
    Iannitto E; Minardi V; Calvaruso G; Mulè A; Ammatuna E; Di Trapani R; Ferraro D; Abbadessa V; Craxí A; Di Stefano R
    Eur J Haematol; 2005 Mar; 74(3):254-8. PubMed ID: 15693796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide.
    Villano JL; Collins CA; Manasanch EE; Ramaprasad C; van Besien K
    Lancet Oncol; 2006 May; 7(5):436-8. PubMed ID: 16648049
    [No Abstract]   [Full Text] [Related]  

  • 14. Pneumocystis jirovecii pneumonia complicating the progress of a patient with glioblastoma multiforme receiving temozolomide.
    Gorospe Sarasúa L; Ureña-Vacas A; Muñoz Del Toro JR
    Arch Bronconeumol; 2016 Oct; 52(10):534-5. PubMed ID: 27021139
    [No Abstract]   [Full Text] [Related]  

  • 15. How lymphotoxic is dose-intensified temozolomide? The glioblastoma experience.
    Wick W; Weller M
    J Clin Oncol; 2005 Jun; 23(18):4235-6; author reply 4236. PubMed ID: 15961774
    [No Abstract]   [Full Text] [Related]  

  • 16. Fatal hepatitis B virus reactivation due to a lamivudine mutant despite undetectable initial viral load.
    Deutsch M; Papadopoulos N; Manolakopoulos S; Hatziyanni E; Vassilopoulos D
    Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):109. PubMed ID: 21139472
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe cholestatic hepatitis due to temozolomide: an adverse drug effect to keep in mind. Case report and review of literature.
    Grieco A; Tafuri MA; Biolato M; Diletto B; Di Napoli N; Balducci N; Vecchio FM; Miele L
    Medicine (Baltimore); 2015 Mar; 94(12):e476. PubMed ID: 25816026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Listeria brain abscess, Pneumocystis pneumonia and Kaposi's sarcoma after temozolomide.
    Ganière V; Christen G; Bally F; Guillou L; Pica A; de Ribaupierre S; Stupp R
    Nat Clin Pract Oncol; 2006 Jun; 3(6):339-43; quiz following 343. PubMed ID: 16757971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.
    Brandes AA; Franceschi E; Tosoni A; Blatt V; Pession A; Tallini G; Bertorelle R; Bartolini S; Calbucci F; Andreoli A; Frezza G; Leonardi M; Spagnolli F; Ermani M
    J Clin Oncol; 2008 May; 26(13):2192-7. PubMed ID: 18445844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical case of the month. Hepatitis B reactivation in an Ag HBs negative patient].
    Michels V; Bastens B; Delforge M; Demoulin JC; Sente JM; Plomteux O; Dupont P; Fontaine F
    Rev Med Liege; 2007 Mar; 62(3):135-8. PubMed ID: 17511378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.